Predictive Factors for Poor Progression-free Survival in Patients with Non-small Cell Lung Cancer Treated with Nivolumab. [electronic resource]
Producer: 20171016Description: 5857-5862 p. digitalISSN:- 1791-7530
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal -- adverse effects
- Antineoplastic Agents -- adverse effects
- Biomarkers, Tumor -- blood
- Carcinoma, Non-Small-Cell Lung -- blood
- Disease-Free Survival
- Female
- Humans
- Japan
- Kaplan-Meier Estimate
- L-Lactate Dehydrogenase -- blood
- Lung Neoplasms -- blood
- Male
- Middle Aged
- Multivariate Analysis
- Nivolumab
- Proportional Hazards Models
- Retrospective Studies
- Risk Factors
- Steroids -- therapeutic use
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.